National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Bazedoxifene (Conbriza®) for the treatment of postmenopausal osteoporosis in women at increased risk of fracture.  A significant reduction in the incidence of verterbral fractures has been demonstrated; efficacy on hip fractures has not been established.

Rapid Review

Commenced Completed Outcome
20/09/2011 02/11/2011 Full Pharmacoeconomic Evaluation not Recommended.